通过RNA结合蛋白FUS/TLS破坏雄激素受体-辅助因子相互作用会改变前列腺癌中的雄激素信号传递
G N Brooke1, D A Leach2, R L Culley2
1School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, ESSEX, UK. gbrooke@essex.ac.uk.
Oncogene
|February 6, 2026
概括
在早期前列腺癌中,FUS蛋白抑制雄激素受体 (AR) 活性,作为瘤抑制剂. 它的表达方式随疾病阶段的变化而变化,这表明它在前列腺癌的进展中起着复杂的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 前列腺癌的进展与雄激素受体 (AR) 活性有关,由辅因子调节.
- FUS/TLS是一种多功能蛋白质,以前建议在前列腺癌中发挥瘤抑制作用.
研究的目的:
- 研究FUS在调节前列腺癌中AR活性中的作用.
- 了解前列腺癌不同阶段的FUS表达模式.
主要方法:
- 对LNCaP细胞进行转录基因分析 (RNA-Seq).
- 报告员测定和FUS的特定领域分析.
- 染色体免疫沉 (ChIP) 试验.
- 定量蛋白质组学. 定量蛋白质组学.
主要成果:
- 在很大程度上,FUS与AR调节基因重叠,主要抑制AR信号传递.
- FUS与AR和辅因子相互作用,可能破坏转录复合体组合.
- 在原发性瘤中,FUS的调节下降,但在晚期的,侵袭性前列腺癌阶段则是上调的.
结论:
- 在早期前列腺癌中,FUS作为AR活性和瘤进展的抑制剂,解释其下调.
- 晚期疾病中FUS表达的改变可能表明AR调节控制的丧失,导致瘤的攻击性行为.
相关概念视频
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Cofactors and Coenzymes
87.6K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
87.6K
G-protein Coupled Receptors
132.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.1K
RNA Polymerase II Accessory Proteins
11.0K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.0K
Factors Affecting Protein-Drug Binding: Drug Interactions
607
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
607
Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K


